Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Parabolic Drugs IPO and Standard Chartered IDR.
Parabolic Drugs IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Standard Chartered IDR is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Parabolic Drugs IPO | Standard Chartered IDR | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IDRS |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | ICICI Securities Limited Spa Capital Advisors Ltd |
Bofa Securities India Limited Goldman Sachs (India) Securities Private Limited Jm Financial Limited Kotak Mahindra Capital Company Limited SBI Capital Markets Limited Ubs Securities India Private Limited |
| Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Parabolic Drugs IPO is up to ₹200.00 Cr whereas the issue size of the Standard Chartered IDR is up to ₹2,486.35 Cr. The final issue price of Parabolic Drugs IPO is ₹75.00 per share and of Standard Chartered IDR is ₹104.00 per share.
| Parabolic Drugs IPO | Standard Chartered IDR | |
|---|---|---|
| Face Value | ₹10 per share | |
| Issue Price (Lower) | ₹75.00 per share | ₹100.00 per share |
| Issue Price (Upper) | ₹85.00 per share | ₹115.00 per share |
| Issue Price (Final) | ₹75.00 per share | ₹104.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 80 shares | 200 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 2,66,66,667 shares | 24,00,00,000 shares |
| Issue Size Total (Amount) | up to ₹200.00 Cr | up to ₹2,486.35 Cr |
Parabolic Drugs IPO opens on Jun 14, 2010, while Standard Chartered IDR opens on May 25, 2010. The closing date of Parabolic Drugs IPO and Standard Chartered IDR is Jun 17, 2010, and May 28, 2010, respectively.
| Parabolic Drugs IPO | Standard Chartered IDR | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 14, 2010 | May 25, 2010 |
| Issue Close | Jun 17, 2010 | May 28, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Parabolic Drugs IPO P/E ratio is , as compared to Standard Chartered IDR P/E ratio of .
| Parabolic Drugs IPO | Standard Chartered IDR | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | ||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||
In the Parabolic Drugs IPO retail investors (RII) are offered 91,58,334 shares while in Standard Chartered IDR retail investors are offered 91,58,334 shares. Qualified institutional buyers (QIB) are offered 1,30,83,333 shares in Parabolic Drugs IPO and 8,40,00,000 shares in Standard Chartered IDR.
| Parabolic Drugs IPO | Standard Chartered IDR | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | 1,30,83,333 shares | 8,40,00,000 shares |
| NII | 39,25,000 shares | 4,32,00,000 shares |
| RII | 91,58,334 shares | 7,20,00,000 shares |
| Employee | 5,00,000 shares | 48,00,000 shares |
| Others | ||
| Total | 2,66,66,667 shares | 20,40,00,000 shares |
Parabolic Drugs IPO subscribed 1.04x in total, whereas Standard Chartered IDR subscribed 2.20x.
| Parabolic Drugs IPO | Standard Chartered IDR | |
|---|---|---|
| QIB (times) | 1.48x | 4.15x |
| NII (times) | 1.20x | 1.90x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.40x | 0.25x |
| Employee (times) | 0.11x | 0.20x |
| Other (times) | ||
| Total (times) | 1.04x | 2.20x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
